THE EFFECT OF MOTIVATIONAL INTERVIEWING ON MENOPAUSE MYTHS AND POSTTRAUMATIC GROWTH IN POSTMENOPAUSAL WOMEN:RANDOMIZED CONTROLLED STUDY
12 de mayo de 2026 actualizado por: Hilal Alkan, Inonu University
This randomized controlled study aims to evaluate the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women.
Participants will be randomly assigned to an intervention group receiving four weekly motivational interviewing sessions or a control group receiving usual care.
Outcomes will be assessed before and after the intervention using validated scales.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
Menopause is a biological transition that may affect women physically, psychologically, and socially. Misconceptions regarding menopause may negatively influence adaptation to this period, while positive coping may support posttraumatic growth.
Motivational interviewing is a client-centered counseling approach designed to strengthen intrinsic motivation and promote positive behavioral change. This randomized controlled trial aims to determine the effect of motivational interviewing on menopause myths and posttraumatic growth in postmenopausal women.
The study will be conducted in Family Health Centers in Gaziantep, Turkey, with 96 postmenopausal women randomly assigned to intervention and control groups. The intervention group will receive four weekly face-to-face motivational interviewing sessions lasting 30-45 minutes. The control group will receive usual care without intervention.
Data will be collected at baseline and after intervention using the Menopause Myths Scale and the Posttraumatic Growth Scale.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
96
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Sí
Descripción
Inclusion Criteria:
- Women who have had their last menstrual period between 12 and 36 months ago,
- are literate,
- can read and write in Turkish,
- do not have any problems that may hinder communication, and
- do not have any diagnosed psychiatric illness will be included in the study.
Exclusion Criteria:
- Those receiving HRT treatment,
- Those whose last menstrual period was 36 months or more ago,
- Women receiving oncology treatment.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: grupo de control
Sin intervención
|
|
|
Experimental: intervention group
The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention.
Women were informed about the research, and those wishing to participate were given a voluntary information form to read, and their verbal and written consent was obtained.
Before starting the Motivational Interview sessions, the client was informed about the duration, number, and timing of the sessions.
Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes.
A total of four motivational interview sessions will be conducted with the women in the experimental group, once a week.
All sessions will be conducted by inviting the women to their family physician's office.
During the motivational interview sessions, counseling will be provided on topics related to the menopausal period, aiming to change negative beliefs about menopause myths and increase post-traumatic growth levels.
|
The researcher provided training on motivational interviewing techniques to be applied to the experimental group prior to the intervention.
Women will be informed about the research, and those wishing to participate will be given a voluntary information form to read, and their verbal and written consent will be obtained.
The client will be informed about the duration, number, and timing of the interviews before the start of the MG sessions.
Each motivational interview session with the women in the experimental group is planned to last approximately 30-45 minutes.
A total of four MG sessions will be conducted with the women in the experimental group, once a week.
All sessions will be conducted by inviting the women to their family physician's office.
During the MG sessions, counseling will be provided on topics related to the menopausal period in order to change the women's negative beliefs about menopause myths and to increase their post-traumatic growth levels after menopause.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
MENOPAUSE MYTHS SCALE
Periodo de tiempo: At the beginning and at the end of the 4-week intervention period
|
Women's perceptions of menopause were measured using the Menopause Myths Scale.
|
At the beginning and at the end of the 4-week intervention period
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Post-Traumatic Growth Scale
Periodo de tiempo: At the beginning and at the end of the 4-week intervention period
|
The Post-Traumatic Growth Scale was used to assess the extent to which menopause creates trauma in women's lives.
|
At the beginning and at the end of the 4-week intervention period
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de mayo de 2026
Finalización primaria (Estimado)
1 de octubre de 2026
Finalización del estudio (Estimado)
1 de octubre de 2026
Fechas de registro del estudio
Enviado por primera vez
24 de abril de 2026
Primero enviado que cumplió con los criterios de control de calidad
12 de mayo de 2026
Publicado por primera vez (Actual)
19 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
19 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
12 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 860686
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .